PUBLISHER: The Business Research Company | PRODUCT CODE: 1942558
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942558
Chemotherapy infusion pumps are specialized medical devices used to deliver precise and continuous doses of chemotherapy drugs to cancer patients. They play a crucial role in optimizing drug administration, minimizing side effects, and enabling treatments to be administered over extended periods, whether in a hospital setting or at home.
The primary types of chemotherapy infusion pumps in the market include large volume pumps, syringe pumps, elastomeric pumps, ambulatory infusion pumps, and others. Large volume chemotherapy infusion pumps are designed to administer significant quantities of chemotherapy drugs over extended durations. These pumps can be either disposable or reusable and are utilized by various end users, including hospitals, clinics, home care settings, and other medical environments.
Tariffs are impacting the chemotherapy infusion pumps market by increasing costs for imported electronic components, sensors, batteries, and medical-grade plastics used in pump manufacturing. These cost increases have affected pricing for smart infusion pumps and ambulatory infusion systems, particularly in north america and asia-pacific regions with globalized supply chains. Higher tariffs have raised procurement costs for hospitals and home care providers and slowed replacement cycles. However, tariffs have also encouraged local manufacturing, regional sourcing, and design optimization, supporting long-term supply chain resilience.
The chemotherapy infusion pumps market research report is one of a series of new reports from The Business Research Company that provides chemotherapy infusion pumps market statistics, including chemotherapy infusion pumps industry global market size, regional shares, competitors with a chemotherapy infusion pumps market share, detailed chemotherapy infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy infusion pumps industry. This chemotherapy infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chemotherapy infusion pumps market size has grown strongly in recent years. It will grow from $5.2 billion in 2025 to $5.51 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rising global cancer incidence, increasing use of chemotherapy as a primary treatment, expansion of oncology treatment centers, growing adoption of infusion-based drug delivery, improvements in infusion pump safety standards.
The chemotherapy infusion pumps market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing shift toward outpatient cancer treatment, rising demand for home-based oncology care, growing focus on reducing hospital stay duration, increasing adoption of personalized chemotherapy regimens, expanding access to cancer treatment in emerging markets. Major trends in the forecast period include rising adoption of ambulatory and home-based chemotherapy delivery, increasing demand for precise and controlled drug administration, growing preference for disposable infusion pump systems, expansion of continuous chemotherapy infusion protocols, increasing focus on patient comfort and treatment adherence.
The rising incidence of cancer is expected to drive the growth of the chemotherapy infusion pumps market. Cancer is a group of diseases marked by uncontrolled cell growth and spread within the body, influenced by factors such as lifestyle changes, genetic predispositions, and environmental elements such as smoking, radiation, chemicals, and infections. Chemotherapy infusion pumps support cancer patients by providing accurate, continuous doses of chemotherapy drugs, improving drug administration, and reducing side effects. For example, in February 2024, the World Health Organization, based in Switzerland, projected over 35 million new cancer cases by 2050, up 77% from the 20 million cases estimated for 2022. This rising incidence of cancer is set to boost the demand for chemotherapy infusion pumps.
Key players in the chemotherapy infusion pumps market are developing advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to offer more personalized and precise treatment options. Customizable infusion rates enable healthcare providers to adjust the delivery speed and dosage of chemotherapy drugs according to individual patient needs. For instance, in May 2023, Mindray, a medical device and solution provider from China, launched a new infusion mode called 'Rhythm Dose' in their BeneFusion i/u infusion pump series. This feature is designed to optimize chemotherapy drug delivery, allowing continuous intravenous infusions of multiple drugs at varying rates for more personalized treatment plans.
In November 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Intera Oncology Inc. for an undisclosed amount. Through this acquisition, Boston Scientific seeks to enhance its interventional oncology portfolio by incorporating Intera Oncology's hepatic arterial infusion pump technology and broadening access to more precise, targeted, and effective cancer treatment solutions across global healthcare markets. Intera Oncology Inc. is a US-based medical device company that specializes in implantable pump systems for the direct delivery of chemotherapy to the liver.
Major companies operating in the chemotherapy infusion pumps market are Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Medtronic plc, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Micrel Medical Devices SA, Zyno Medical LLC, Mindray Medical International Limited, Insulet Corporation, Tandem Diabetes Care Inc., CME Medical, Eitan Medical, Codan Medizinische Gerate GmbH & Co KG, SOOIL Development Co Ltd, Q-Core Medical Ltd.
North America was the largest region in the chemotherapy infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chemotherapy infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The chemotherapy infusion pumps market consists of sales of portable elastomeric infusion pumps, electronic infusion pumps, implantable infusion pumps, and patient-controlled analgesia (PCA) pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chemotherapy Infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses chemotherapy infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for chemotherapy infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemotherapy infusion pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.